The Dimethyltryptamine-Forming Enzyme in Blood Platelets: A Study in Monozygotic Twins Discordant for Schizophrenia
Abstract
Samples of the nondialyzed platelets of l4 pairs of monozygotic twins discordant for schizophrenia were assayed for their ability to enzymatically form the hallucinogen dimethyltryptamine. The schizophrenic twins had higher mean levels of enzyme activity than their non-schizophrenic co-twins, whose mean level of enzyme activity was equal to that of 22 normal subjects. This finding suggests that the higher levels of enzyme activity found in schizophrenics is produced by their environment and is not genetically determined.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
